Jerry Ingram
Articles
R-CHOP is standard of care for advanced DLBCL patients
November 1st 2007Rituximab (Rituxan) plus CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) is the standard induction therapy for patients with advanced-stage diffuse large B-cell lymphoma, including both elderly and younger patients.
